Outcome of Board Meeting

| Updated on June 09, 2011 Published on June 09, 2011

Techtran Polylenses Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2011, inter alia, have transacted the following business:

1. Considered and approved the Scheme of Amalgamation of M/s. Hemarus Therapeutics Ltd. with M/s. Techtran Polylenses Ltd.

2. The Ratio of exchange of shares between the Companies is fixed as:

For every 1 share of M/s. Hemarus Therapeutics Ltd., 1.14 shares of M/s. Techtran Polylenses Ltd. will be allotted.

3. Considered and approved for Incorporating a wholly owned Non Banking Finance Company.

Source : BSE - >www.bseindia.com

Published on June 09, 2011
This article is closed for comments.
Please Email the Editor